Izafe Group
0.248
SEK
+3.33 %
Less than 1K followers
IZAFE B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+3.33%
-4.62%
+14.81%
+15.89%
+20.39%
+7.36%
-68.08%
-87.83%
-92.85%
iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions. The company offers products such as Dosell, a pharmaceutical robot, and the SaaS solution Pilloxa, a connected dose bag. The products aim to reduce the risk of incorrect medication. The customers are private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group has its headquarters in Stockholm.
Read moreMarket cap
79.79M SEK
Turnover
17.01K SEK
Revenue
7.95M
EBIT %
-244.4 %
P/E
-
Dividend yield-%
-
Financial calendar
25/4
2025
Interim report Q1'25
28/5
2025
General meeting '25
29/8
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
March Monthly Update – Continued Growth and Important Progress
iZafe Group AB byter Certified Adviser till Carnegie Investment Bank AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools